CryoPort, Inc. (CYRX.OB) on Thursday said it has named Stephen Wasserman, 65, to its Board of Directors. He replaces Carlton Johnson, who resigned from the Board earlier this month.
CryoPort provides cold chain frozen shipping systems primarily to the biotechnology, pharmaceutical, and life science industries. Wasserman has over 30 years of senior operating and financial management experience in the medical device and healthcare industries.
Wasserman is currently on the Board of the medical diagnostics firm Iris International and serves as chairman of the compensation committee.
Previously he was group vice president of the Diagnostic Systems Products division of medical technology firm Olympus America as well as a member of the executive committee for American Operations.
Larry Stambaugh, CryoPort's chairman and chief executive officer, said, "Stephen's experience managing highly successful medical device and diagnostic companies will be extremely valuable to CryoPort as we accelerate our commercial activities this year. We look forward to drawing on Stephen's in-depth knowledge of our target markets and his proven ability to drive the introduction of new technologies and products."
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.